Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Checkpoint Therapeutics (CKPT) PT Raised to $20 at Cantor Fitzgerald Following Positive Data
-
Eli Lilly's (LLY) tirzepatide Has Multi-Billion Opportunities Outside of Diabetes, Currently Undervalued - Cantor Fitzgerald
-
Greystone Continues Growth of CMBS Platform with New Hires
-
No Fundamental Reason of I-Mab's (IMAB) Weakness, Risk-Reward is to The Upside - Cantor Fitzgerald
-
Johnson & Johnson's (JNJ) Potential to Change Multiple Myeloma Treatment Paradigm in Underappreciated, Stock Remains Top Pick - Cantor Fitzgerald
-
IPO for SPAC HCM Acquisition Corp (HCMA) Opens at $10
-
HCM Acquisition Corp Announces Pricing of $250 Million Initial Public Offering
-
HCM Acquisition Corp Announces Pricing of $250 Million Initial Public Offering
-
Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II (SPKB)
-
Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II
-
Emergent BioSolutions (EBS) PT Raised to $55 at Cantor Fitzgerald
-
Atlantic Coastal Acquisition Corp. II, a Special Purpose Acquisition Company, Announces Closing of Upsized $300,000,000 Initial Public Offering and Listing On NASDAQ
-
Papaya Growth Opportunity Corp. I Announces Closing of $287.5 Million Initial Public Offering
-
Papaya Growth Opportunity Corp. I Announces Closing of $287.5 Million Initial Public Offering
-
Bicycle Therapeutics Plc (BCYC), Jazz Pharmaceuticals (JAZZ) and SAGE Therapeutics (SAGE) - Needham's Favorite 2022 Biotech Picks
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Dec 31
-
EyePoint Pharmaceuticals (EYPT) is a Potential Acquisition Target, But Well-Positioned to Execute on its Own - Cantor Fitzgerald
-
Tempo Automation, Inc. Secures $200 Million Convertible Note Financing Led by Oaktree
-
Form 4 CF ACQUISITION CORP. IV For: Jan 13 Filed by: CANTOR FITZGERALD, L. P.
-
Silver Spike Investment Corp. Announces Proposed Initial Public Offering
-
Form 424B3 Cantor Fitzgerald Income
-
Vox Royalty Corp (VOX:CN) (VOXCF) PT Raised to Cdn$3.16 at Cantor Fitzgerald
-
Houlihan Lokey Capital Markets Group Expands Its Growth Capital and Equity Solutions Practice
-
Secretary Steven Mnuchin’s Liberty Strategic Capital to Invest $150 Million in Satellogic and CF Acquisition Corp. V (CFV)
-
Liberty Strategic Capital to Lead Investment in Satellogic, an Emerging Leader in Earth-Observation Satellites
-
Secretary Steven Mnuchin’s Liberty Strategic Capital to Invest $150 Million in Satellogic and CF Acquisition Corp. V (Nasdaq: CFV)
-
Omeros Corp. (OMER) PT Lowered to $20 at Cantor Fitzgerald
-
10X Capital Venture Acquisition Corp. III Announces Closing of Upsized $300 Million Initial Public Offering
-
10X Capital Venture Acquisition Corp. III Announces Closing of Upsized $300 Million Initial Public Offering
-
Papaya Growth Opportunity Corp. I (PPYAU) Prices 25M Unit IPO at $10/unit
-
Papaya Growth Opportunity Corp. I Announces Pricing of $250 Million Initial Public Offering
-
Papaya Growth Opportunity Corp. I Announces Pricing of $250 Million Initial Public Offering
-
Atlantic Coastal Acquisition Corp. II Announces Pricing of Upsized $261,000,000 Initial Public Offering
-
Orchid Island Capital Announces Estimated Fourth Quarter 2021 Results, January 2022 Monthly Dividend and December 31, 2021 RMBS Portfolio Characteristics
-
VYNE Therapeutics (VYNE) MST Sale is Good news, Underscores Company's Ability to Execute - Cantor Fitzgerald
-
C5 Acquisition Corporation Completes $287.5 Million Initial Public Offering
-
Cantor Fitzgerald Assumes Aspira Women’s Health (AWH) at Overweight
-
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List
-
10X Capital Venture Acquisition Corp. III (VCXB.U) Prices 26.1M Unit IPO at $10/unit
-
Analysis-Buy the bounce? Investors watch valuations, technical levels to decide
-
10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering
-
10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering
-
OrganiGram Holdings Inc (OGI:CN) (OGI) PT Lowered to Cdn$5.30 at Cantor Fitzgerald
-
Tilray (TLRY) PT Lowered to $6.90 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Bionomics Ltd. (BNOX) at Overweight
-
Cantor Fitzgerald Starts Contango Ore (CTGO) at Overweight
-
IPO for SPAC C5 Acquisition Corp (CXAC) Opens at $10.04
-
Cantor Fitzgerald and Capital Innovations Announce Plans to Launch Sustainable Infrastructure Fund
-
C5 Acquisition Corporation Announces Pricing of $250 Million Initial Public Offering
-
Form N-2 CANTOR FITZGERALD SUSTAI

